)
Alivus Life Sciences (ALVUS) investor relations material
Alivus Life Sciences Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3FY26 delivered record revenue of INR 673 crores (6,729 Mn), up 14.4% QoQ and 4.8% YoY, with broad-based strength across segments and geographies.
CDMO business rebounded strongly, with 100% QoQ and 85.3% YoY revenue growth, driven by new project ramp-up.
Non-GPL business grew 16.1% for nine months, reflecting successful diversification and robust demand in key markets like Europe, Japan, LATAM, ROW, and India.
Board approved unaudited financial results for Q3 and nine months ended December 31, 2025, reviewed by the Audit Committee and statutory auditor.
Financial highlights
Q3FY26 revenue from operations was INR 673 crores (6,729 Mn), up 14.4% QoQ and 4.8% YoY; 9MFY26 revenue reached INR 1,863 crores (18,627 Mn), up 7.2% YoY.
Gross margin for Q3FY26 was 58.9%, up 330 bps YoY; EBITDA margin reached 36.4%, up 510 bps YoY.
PAT for Q3FY26 was INR 150 crores (1,503 Mn), with a PAT margin of 22.3%.
Free cash flow for nine months FY26: INR 221 crores (2,207 Mn); cash and equivalents at INR 733 crores (7,330 Mn) as of Dec 31, 2025.
Earnings per share (basic) for Q3FY26 was INR 12.25, compared to INR 11.18 in Q3FY25.
Outlook and guidance
High single-digit revenue growth guided for FY26 and FY27, with margins expected in the 30%-32% range, above prior guidance.
CapEx for FY26 revised to INR 450 crores, with INR 150 crores deferred to FY27.
Double-digit growth anticipated from FY28 as Solapur capacity comes fully online.
Company continues to monitor regulatory developments regarding new labour codes and will adjust accounting as needed.
- TimeTickerHeadlineOpen
- 7 FebGICRE
Net profit for the nine months surged to ₹6,62,217 lakhs, with a robust solvency ratio of 3.87. - 7 Feb517271
Strong revenue and profit growth, interim dividend, and major investments approved. - 7 Feb514167
Quarterly and nine-month results reflect solid revenue, profit, and compliance with new labour codes. - 7 FebMGL
Strong revenue growth offset by lower margins and profit; interim dividend declared. - 7 FebPGIL
Strong revenue and margin growth, with India set for further expansion and upgraded ratings. - 7 Feb504614
Strong revenue and profit growth in Q3 FY26, led by power and steel segments. - 7 FebCHEMPLASTS
Net losses widened and revenue fell year-over-year amid regulatory and market headwinds. - 7 FebSBIN
Q3 FY26 net profit reached ₹21,028.15 crore, driven by robust income and strategic divestments. - 6 FebHTOO
Resale registration for 71,429 shares via warrant, with proceeds only on exercise; financial risks persist. - 6 FebVSAT
Q3 revenue up 3% to $1.16B, net income $25M, strong cash flow, Ligado boost, satellite focus.
Next Alivus Life Sciences earnings date
Next Alivus Life Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)